A deep dive into Zydus Wellness Ltd. (ZYDUSWELL) — examining the financials, valuation picture, and who owns the stock.
Zydus Wellness Revenue Trend
Year-over-year, Zydus Wellness Ltd. grew revenue by 16.3% — from ₹2,342 Cr in FY2024 to ₹2,722 Cr in FY2025.
The bigger picture is compelling: a 20.2% annual growth rate over 10 years took revenue from ₹431 Cr to ₹2,722 Cr.
Zydus Wellness Ltd.'s ₹2,722 Cr revenue base puts it in the mid-sized bracket among food and food processing companies in India.
It's been 9 years of continuous revenue growth for Zydus Wellness Ltd. — a pattern worth noting.
| Year | Revenue | YoY % |
|---|---|---|
| FY2025 | ₹2,722 Cr | +16.3% |
| FY2024 | ₹2,342 Cr | +3.6% |
| FY2023 | ₹2,260 Cr | +11.9% |
| FY2022 | ₹2,020 Cr | +7.7% |
| FY2021 | ₹1,876 Cr | — |
View Zydus Wellness Ltd.'s full 10-year revenue trend with CAGR analysis →
Zydus Wellness Profitability
Bottom-line growth was evident, with Zydus Wellness Ltd. posting ₹347 Cr in net profit for FY2025 — up 30.0% from ₹267 Cr.
On the margin front, there's improvement — net margin went from 11.4% in FY2024 to 12.7% in FY2025.
Diluted EPS came in at ₹10.90 for FY2025, up from ₹8.39 a year earlier.
Is Zydus Wellness Undervalued
Under the P/E Ratio approach, Zydus Wellness Ltd.'s estimated fair value is ₹417 (17.1% downside).
Zydus Wellness Ltd. shares are currently trading at ₹502.65.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹417 | 17.1% downside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Zydus Wellness Ltd. with detailed assumptions →
Zydus Wellness Shareholding Pattern
At 69.6%, the promoter stake has been flat for the past 4 quarters.
FII holding stands at 3.2%, down from 3.2% in the year-ago quarter.
Domestic institutional investors (DIIs) held 18.9% as of March 2026, down from 19.3% a year ago.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 69.6% | 3.2% | 18.9% | 8.3% |
| Dec 2025 | 69.6% | 3.3% | 18.6% | 8.5% |
| Sep 2025 | 69.6% | 3.4% | 18.8% | 8.2% |
| Jun 2025 | 69.6% | 3.2% | 19.3% | 7.8% |
Track quarterly shareholding changes for Zydus Wellness Ltd. →
Zydus Wellness Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2025 total assets: ₹64.42B (up 4.8% YoY from ₹61.48B).
Top categories: Intangibles & Goodwill (75.0%), Inventories (8.0%), Receivables (5.7%).
Of the ₹64.42B in liabilities and equity, 88.0% is shareholder equity, 2.9% is interest-bearing debt, and 9.0% is operating liabilities. Over the year, debt is down 42.7% and equity is up 5.9%.
Balance sheet composition — FY 2025
| Category | Value |
|---|---|
| Cash & ST Investments | 1.02B |
| Receivables | 3.67B |
| Inventories | 5.18B |
| Property, Plant & Equipment | 3.06B |
| Investments | 7.00M |
| Intangibles & Goodwill | 48.35B |
| Other Assets | 3.14B |
| Category | Value |
|---|---|
| Equity | 56.72B |
| Short-term Debt | 1.87B |
| Long-term Debt | 14.00M |
| Trade Payables | 4.29B |
| Other Liabilities | 1.53B |
Zydus Wellness Stock Analysis
Here's the bottom line on Zydus Wellness Ltd. (ZYDUSWELL) based on the latest available financials.
Revenue of ₹2,722 Cr in FY2025, up 16.3% year-over-year.
Long-term revenue has been compounding at 20.2% annually over 10 years.
The company is profitable, with a net margin of 12.7% and net income of ₹347 Cr.
The P/E Ratio model implies 17.1% downside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
Want to dig deeper? Craytheon's platform provides 10 years of financial data, three valuation models, and insider trading activity for Zydus Wellness Ltd..